Multilab-Logo, India
 New No.3, Appaiar Lane, Second Floor, Royapuram, Chennai - 600 013, Tamilnadu, India
 Email - 0, Phone - +9144 25984175,  Mobile - +91 94441 62346    
FAQ
Language    Search
  Cleanrooms Laboratory
  Pharmaceutical Testing



FAQ > Glossary of Terms > I Series > Impurity Profile
 

Cleanrooms Information

Pharmaceutical & Cleanroom Glossary of Terms


IBC(Intermediate Bulk Container), IDLH(Immediately Dangerous to Life and Health), Immune Response, Immuno Electrophoresis, Immunity, Immunogen, Immunoglobulin-Ig, Immunoglobulin A - IgA, Immunoglobulin(IgA, IgD, IgE, IgG, IgM), Immunology, Immunoproteins, Imprinting, Impurity, Impurity Profile, Inactive Ingredient, Inactivation, Incidential Release, Inclusion Body, Inclusions, IND(Investigational New Drug) Application, Indirect Impact System, Inert, Infarct, Infected, Infectious, Infectious Agent, Infiltration, Informatics, Infusion, Injection, In-line, In-process Control, Innocuous, Inoculum


Learn About Deadly Cancer Mesothelioma due to Asbestos Exposure, it can affect any one in the world

Impurity Profile
A description of the identified and unidentified impurities present in a typical batch of API (Active Pharmaceutical Ingredient) produced by a specific controlled production process. It includes the identity or some qualitative analytical designation (e.g. retention time), the range of each impurity observed, and type of each identified impurity. For each API there should be an impurity profile describing the identified and unidentified impurities present in a typical batch. The impurity profile is normally dependent upon the process or origin of the API.